Browse by Audience
Skip to content
Papers of the Week
Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients.
Authors
Abstract
There is an unmet medical need for pruritus associated with chronic kidney disease, a distressing complication characterized by generalized and persistent itch affecting 20% to 40% of patients undergoing hemodialysis. Here we report the results of a phase 2 trial evaluating the efficacy and safety of a novel peripherally restricted kappa opioid receptor agonist, difelikefalin, in adult patients undergoing hemodialysis with pruritus.